EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and Clinical Validation of a Novel Inflamm-Aging Score in Cardiovascular Disease

Aiad Gaber Arean, Amenh Mohammed Abdulrahman, Abdullah Ali Mohammed, Waleed Khalid Ahmed, Youssef Shakuri Yasin, Azal Hamoody Jumaa

Kurdistan Journal of Applied Research · 24.06.2026 · 11 (1) · 207-221

DOI: 10.24017/science.2026.1.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kurdistan Journal of Applied Research, online erschienen am 24.06.2026. Verfasst von Aiad Gaber Arean und 5 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic low-grade inflammation associated with aging "inflamm-aging" contributes to cardiovascular disease (CVD), yet traditional risk assessment relies on single biomarkers. This cross-sectional study aims to evaluate and validate a composite inflamm-aging score in 65 patients with CVD and 55 age-matched healthy controls. The score was derived from three biomarkers of interleukin 6 (IL-6), high-sensitivity c-reactive protein (hsCRP), and matrix metalloproteinase-9 (MMP9)- using principal component analysis (PCA). The PCA yielded one component with an eigenvalue of 2.172 (72.4% variance), and the second component's eigenvalue was 0.52 (1.20) with 81.5% sensitivity and 87.3% specificity. The score correlated strongly with N-terminal pro-B-type natriuretic peptide (ρ=0.71) and the soluble suppression of tumorigenicity 2 (ρ=0.58), independent of traditional risk factors including hypertension, diabetes, and dyslipidemia. A significant age-by-disease interaction (p=0.008) indicated accelerated inflamm-aging in older CVD patients. The inflamm-aging score is a promising novel biomarker of CVD severity beyond traditional assessments, potentially guiding individualized anti-inflammatory therapy. Independent external validation is required before clinical implementation.

Zitieren

APA

Arean, A. G., Abdulrahman, A. M., Mohammed, A. A., Ahmed, W. K., Yasin, Y. S., & Jumaa, A. H. (2026). Development and Clinical Validation of a Novel Inflamm-Aging Score in Cardiovascular Disease. Kurdistan Journal of Applied Research, 11(1), 207-221. https://doi.org/10.24017/science.2026.1.14

Vancouver

Arean AG, Abdulrahman AM, Mohammed AA, Ahmed WK, Yasin YS, Jumaa AH. Development and Clinical Validation of a Novel Inflamm-Aging Score in Cardiovascular Disease. Kurdistan Journal of Applied Research. 2026;11(1):207-221. doi:10.24017/science.2026.1.14

BibTeX
@article{Arean2026,
  author = {Arean, Aiad Gaber and Abdulrahman, Amenh Mohammed and Mohammed, Abdullah Ali and Ahmed, Waleed Khalid and Yasin, Youssef Shakuri and Jumaa, Azal Hamoody},
  title = {Development and Clinical Validation of a Novel Inflamm-Aging Score in Cardiovascular Disease},
  journal = {Kurdistan Journal of Applied Research},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {207--221},
  doi = {10.24017/science.2026.1.14}
}
Kostenlos starten →